Balance Sheet Data
Alpine Immune Sciences, Inc. (ALPN)
$8.01
-0.15 (-1.84%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 81.24 | 52.30 | 40.52 | 105.58 | 120.77 | 2,027.37 | 5,449.37 | 14,647.37 | 39,370.70 | 105,824.58 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.13 | 0.24 | 0.69 | 0.39 | 25 | 24.10 | 64.78 | 174.12 | 468.02 | 1,257.99 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 0.19 | 1.72 | 1.54 | 0.58 | 3.35 | 45.84 | 123.22 | 331.20 | 890.23 | 2,392.85 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.59 | -0.50 | -0.82 | -0.80 | -9.37 | -25.18 | -67.68 | -181.92 | -488.99 | -1,314.34 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.